New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma Meeting Abstract
| Authors: | Aggen, D. H.; Garcia, A.; Saro Suarez, J. M.; Sauer, A.; Cristiani, S.; Brophy, F. E.; Streets, S.; Norry, E.; Nelson, A. A.; Kilari, D.; Garmezy, B.; Charlson, J. A.; Zugazagoitia, J.; Calvo, E.; Moreno, I.; Moreno, V.; Hoimes, C. J.; Hong, D. S.; Cervantes, A. |
| Abstract Title: | New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900410 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.TPS708 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS708 -- Source: Wos |
